Skip to main content
. 2023 Dec 22;5(1):80–86. doi: 10.1016/j.xfre.2023.12.004

Table 3.

Baseline vs. 4-/8-week outcome comparisons (t-tests): mean (95% confidence interval).

Overall
P values
Baseline 4 wk 8 wk Baseline vs. 4 wk Baseline vs. 8 wk
Glucose 89.5 (86.6–92.5) 90.5 (86.2–94.9) 92.3 (89.7–95.0) .64 .063
Insulin 20.6 (15.4–25.8) 21.1 (15.1–27.0) 20.7 (15.5–25.8) .81 .57
HOMA-IR 4.6 (3.4–5.7) 4.8 (3.2–6.3) 4.5 (3.2–5.7) .69 .89
Moderate arm P values
Baseline 4 wk 8 wk Baseline vs. 4 wk Baseline vs. 8 wk
Glucose 91.5 (88.2–94.9) 89.7 (82.9–96.5) 91.4 (87.8–95.0) .56 .79
Insulin 23.2 (16.0–30.5) 23.2 (13.6–32.9) 22.4 (15.0–29.7) .99 .81
HOMA-IR 5.3 (3.6–7.0) 5.3 (2.7–8.0) 4.7 (2.7–6.6) .99 .56
Vigorous arm P values
Baseline 4 wk 8 wk Baseline vs. 4 wk Baseline vs. 8 wk
Glucose 86.8 (81.1–92.4) 91.6 (85.2–98.1) 93.5 (88.7–98.3) .06 .007
Insulin 17.0 (8.5–25.5) 18.1 (10.5–25.7) 18.5 (9.4–27.5) .64 .42
HOMA-IR 3.6 (2.0–5.2) 4.0 (2.5–5.6) 4.2 (2.3–6.2) .3 .19

Note: Mean (95% confidence intervals for all values). The exact baseline values vary slightly on the basis of metric; the values compared with those in 4 weeks are displayed. The nonparametric test (Wilcoxon sign-rank) similar results are not displayed. Bold P-values denote significance.

HOMA-IR = homeostatic model assessment for insulin resistance.